A study of beta 2-microglobulin skin deposits in dialyzed patients and healthy controls.
This study reports on beta 2-microglobulin (beta 2M) deposits in the skin of 12 uremic patients and three kidney transplant recipients compared with eight healthy controls. Uremic patients were treated by hemodialysis (HD), hemofiltration (HF), hemodiafiltration (HDF), or continuous ambulatory peritoneal dialysis (CAPD) for a period lasting from 1 to 19 years. Congo red staining of the skin was negative in patients and controls. However, immunofluorescent staining with an anti-beta 2-microglobulin monoclonal antibody was positive in the skin of all patients and of six of the eight controls. Beta 2M skin deposition is more intense in patients than in controls and increases with patient age and the duration of dialysis. A stron correlation is observed between the extent of skin beta 2M deposits and clinical manifestations due to beta 2M deposits in internal organs. However, no correlation is found between beta 2M skin deposits and sex or beta 2M serum levels.
Assounga
A G
AG
Department of Nephrology, Centre Hospitalier Universitaire, Montpellier, France.
Bascoul
S
S
Canaud
B
B
Bouya
P A
PA
Vendrell
J P
JP
Sciolla
J P
JP
Mourad
G
G
Baldet
P
P
Serre
A
A
Mion
C
C
D000328:Adult; D000368:Aged; D001706:Biopsy; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012867:Skin / Q000032:analysis*; D001613:beta 2-Microglobulin / Q000032:analysis*
D001613:beta 2-Microglobulin